On November 6, MSCI announced the results of its November index review. The adjustments will take effect after the market close on November 24.
According to Zhitong Finance, on November 6, MSCI Inc. announced the results of its November index review. The adjustments will take effect after the market close on November 24. The MSCI Global Small Cap Index will include 22 individual stocks such as Ascletis Pharma (01672), Beautiful Life Healthcare (02373), China Resources Pharmaceutical (03320), Cirrus (2507), Chabaidao (02555), and Youzan (08083).
At the same time, 17 stocks, including China Gold International Resources (02099), China Nonferrous Metal Mining (01258), JL MAG Rare-Earth Co., Ltd. (06680), and Yangtze Optical Fibre and Cable (06869), will be removed.
In addition, the MSCI Hong Kong Index will include seven individual stocks such as Chow Sang Sang (00116), Great Eagle Holdings (00041), and MGM China (02282). Meanwhile, CARsgen Therapeutics (02171) and Hutchison Telecommunications Hong Kong (00215) will be removed.
